Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-25-000059
Filing Date
2025-08-05
Accepted
2025-08-05 08:50:46
Documents
2
Period of Report
2025-08-05

Document Format Files

Seq Description Document Type Size
1 6-K form6kagm2025announcement.htm 6-K 17859
2 EX-99.1 a2025agmannouncementpr.htm EX-99.1 12109
  Complete submission text file 0001129928-25-000059.txt   30957
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 251183112
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)